WuXi XDC and AbTis Sign Memorandum of Understanding for Development and Manufacturing of Antibody Drug Conjugates Read more
ADC Therapeutics Announces Exclusive License Agreement with Sobi to Develop and Commercialize ZYNLONTA (loncastuximab tesirine-lpyl) in Europe and Select International Territories Read more
Pfizer and BioNTech Announce FDA Approval of their COVID-19 Vaccine COMIRNATY For Adolescents 12 through 15 Years of Age Read more
FDA Approves KRYSTEXXA (pegloticase) Injection Co-Administered With Methotrexate, Expanding the Labeling to Help More People with Uncontrolled Gout Achieve a Complete Response to Therapy Read more
Network with Johnson & Johnson, Springboard, BSI, AstraZeneca and many more at the Wearable Injectors & Connected Devices Conference Read more
Exelixis and Ryvu Therapeutics Establish Exclusive License Agreement to Develop Novel STING Agonist-Based Targeted Cancer Therapies Read more
BeiGene Announces Strategic Research Collaboration with InnoRNA to Jointly Discover Novel mRNA Therapies Read more
Brii Biosciences Announces Commercial Launch of its Amubarvimab/Romlusevimab Combination Therapy for COVID-19 in China Read more
FDA grants Priority Review to Roche’s Lunsumio for people with relapsed or refractory follicular lymphoma Read more